HER2:Trastuzumab Deruxtecan

Glori Das1,2, Stephen T C Wong1,2, Hong Zhao1

  • 1Department of Systems Medicine and Bioengineering, Houston Methodist Neal Cancer Center, Houston Methodist Hospital, Weill Cornell Medical College, Houston, TX 77030, USA.

Cancers
|October 26, 2024
PubMed
概括

特拉斯图祖马布德鲁克斯泰坎在HER2阳性乳腺癌中对大脑转移有希望. 这种疗法也可能有利于患有HER2-低或HER2-零瘤的患者,为难以治疗的病例提供新的希望.